​

Alvotech (ALVO) Stock Forecast, Price Target & Predictions

OverviewOwnershipChartTranscripts

ALVO Stock Forecast

Alvotech (ALVO) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $9.50, with a high of $10.00 and a low of $8.00. This represents a 104.74% increase from the last price of $4.64.

- $4 $8 $12 $16 $20 High: $10 Avg: $9.5 Low: $8 Last Closed Price: $4.64

ALVO Stock Rating

Alvotech stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (60.00%), 2 Hold (40.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 2 3 Strong Sell Sell Hold Buy Strong Buy

ALVO Price Target Upside V Benchmarks

TypeNameUpside
StockAlvotech104.74%
SectorHealthcare Stocks 15.45%
IndustrySpecialty & Generic Drug Manufacturers Stocks20.46%

Price Target Trends

1M3M12M
# Anlaysts255
Avg Price Target$10.00$10.40$10.40
Last Closing Price$4.64$4.64$4.64
Upside/Downside115.52%124.14%124.14%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Dec, 25131--5
Nov, 2514---5
Oct, 25-41--5
Sep, 25-32--5
Aug, 25-32--5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Dec 03, 2025Morgan Stanley$10.00$4.60117.39%115.52%
Nov 18, 2025UBS$10.00$5.1195.69%115.52%
Nov 04, 2025Northland Securities$10.00$4.93102.84%115.52%
Nov 04, 2025Niall AlexanderDeutsche Bank$8.00$5.0359.05%72.41%
Oct 14, 2025Morgan Stanley$14.00$7.9775.66%201.72%
May 24, 2024Balaji PrasadBarclays$22.00$13.5862.00%374.14%
May 21, 2024Balaji PrasadBarclays$20.00$13.7645.35%331.03%
Jan 29, 2024Balaji PrasadBarclays$17.00$15.2511.48%266.38%
Jul 01, 2022Emmanuel PapadakisDeutsche Bank$10.00$8.2121.80%115.52%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 04, 2025Deutsche BankBuyHolddowngrade
Oct 14, 2025Morgan StanleyOverweightupgrade
Sep 23, 2025Deutsche BankHoldBuyupgrade
May 21, 2024BarclaysOverweightOverweighthold
Jan 29, 2024BarclaysOverweightupgrade
Oct 20, 2023CitigroupNeutralupgrade
Jul 01, 2022Deutsche BankHoldinitialise

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-2.60------
Avg Forecast$-1.15$-1.10$-0.41$0.16$0.57$0.63$0.92
High Forecast$-1.01$-0.96$-0.35$0.21$0.87$0.71$1.04
Low Forecast$-1.28$-1.24$-0.46$0.08$0.26$0.55$0.80
Surprise %126.09%------

Revenue Forecast

$0 $400M $800M $1B $2B $2B Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$83.03M$91.43M-----
Avg Forecast$108.84M$86.00M$454.36M$676.91M$948.70M$1.30B$1.42B
High Forecast$118.78M$124.49M$485.30M$717.63M$948.70M$1.30B$1.56B
Low Forecast$98.82M$47.50M$423.42M$636.18M$948.70M$1.30B$1.27B
Surprise %-23.71%6.32%-----

Net Income Forecast

$-600M $-430M $-260M $-90M $80M $250M Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-513.58M$-551.73M-----
Avg Forecast$-260.28M$-250.25M$-92.00M$46.36M$191.55M$142.38M$209.08M
High Forecast$-229.14M$-217.75M$-80.05M$46.64M$198.74M$160.87M$235.42M
Low Forecast$-291.19M$-282.75M$-103.94M$18.65M$59.12M$123.89M$181.31M
Surprise %97.32%120.47%-----

ALVO Forecast FAQ

Is Alvotech stock a buy?

Alvotech stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Alvotech is a favorable investment for most analysts.

What is Alvotech's price target?

Alvotech's price target, set by 5 Wall Street analysts, averages $9.5 over the next 12 months. The price target range spans from $8 at the low end to $10 at the high end, suggesting a potential 104.74% change from the previous closing price of $4.64.

How does Alvotech stock forecast compare to its benchmarks?

Alvotech's stock forecast shows a 104.74% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the specialty & generic drug manufacturers stocks industry (20.46%).

What is the breakdown of analyst ratings for Alvotech over the past three months?

  • December 2025: 20.00% Strong Buy, 60.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 20.00% Strong Buy, 80.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 0% Strong Buy, 80.00% Buy, 20.00% Hold, 0% Sell, 0% Strong Sell.

What is Alvotech’s EPS forecast?

Alvotech's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.41, marking a 0% decrease from the reported $0 in 2023. Estimates for the following years are $0.16 in 2025, $0.57 in 2026, $0.63 in 2027, and $0.92 in 2028.

What is Alvotech’s revenue forecast?

Alvotech's average annual revenue forecast for its fiscal year ending in December 2024 is $454.36M, reflecting a 396.92% increase from the reported $91.43M in 2023. The forecast for 2025 is $676.91M, followed by $948.7M for 2026, $1.3B for 2027, and $1.42B for 2028.

What is Alvotech’s net income forecast?

Alvotech's net income forecast for the fiscal year ending in December 2024 stands at $-91.997M, representing a -83.33% decrease from the reported $-552M in 2023. Projections indicate $46.36M in 2025, $191.55M in 2026, $142.38M in 2027, and $209.08M in 2028.